Evidence map›Paper›PMID 30646511›Full record

ArticleInternational journal of molecular sciences2019

The Role of Dimethyl Sulfoxide (DMSO) in Gene Expression Modulation and Glycosaminoglycan Metabolism in Lysosomal Storage Disorders on an Example of Mucopolysaccharidosis.

Marta Moskot, Joanna Jakóbkiewicz-Banecka, Anna Kloska, Ewa Piotrowska, Magdalena Narajczyk, Magdalena Gabig-Cimińska

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Food science & nutrition · 2025
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Unveiling the therapeutic potential ofFrontiers in pharmacology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Marta MoskotInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Laboratory of Molecular Biology, Wita Stwosza 59, 80-308 Gdańsk, Poland. marta.moskot@biol.ug.edu.pl.ORCID 0000-0002-7342-9372
Joanna Jakóbkiewicz-BaneckaDepartment of Medical Biology and Genetics, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland. joanna.jakobkiewicz-banecka@biol.ug.edu.pl.
Anna KloskaDepartment of Medical Biology and Genetics, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland. anna.kloska@biol.ug.edu.pl.ORCID 0000-0002-5168-0232
Ewa PiotrowskaDepartment of Molecular Biology, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland. ewa.piotrowska@biol.ug.edu.pl.
Magdalena NarajczykLaboratory of Electron Microscopy, Faculty of Biology, University of Gdańsk, Wita Stwosza 59, 80-308 Gdańsk, Poland. magdalena.narajczyk@biol.ug.edu.pl.
Magdalena Gabig-CimińskaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Laboratory of Molecular Biology, Wita Stwosza 59, 80-308 Gdańsk, Poland. m.gabig@biol.ug.edu.pl.ORCID 0000-0002-2664-8724
Gdańsk Medical University · PLInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PLUniversity of Gdańsk · PL

Funding

Narodowe Centrum Nauki UMO-2011/01/B/NZ1/03686
6 · The paper itself

Abstract

Obstacles to effective therapies for mucopolysaccharidoses (MPSs) determine the need for continuous studies in order to enhance therapeutic strategies. Dimethyl sulfoxide (DMSO) is frequently utilised as a solvent in biological studies, and as a vehicle for drug therapy and the in vivo administration of water-insoluble substances. In the light of the uncertainty on the mechanisms of DMSO impact on metabolism of glycosaminoglycans (GAGs) pathologically accumulated in MPSs, in this work, we made an attempt to investigate and resolve the question of the nature of GAG level modulation by DMSO, the isoflavone genistein solvent employed previously by our group in MPS treatment. In this work, we first found the cytotoxic effect of DMSO on human fibroblasts at concentrations above 3%. Also, our results displayed the potential role of DMSO in the regulation of biological processes at the transcriptional level, then demonstrated a moderate impact of the solvent on GAG synthesis. Interestingly, alterations of lysosomal ultrastructure upon DMSO treatment were visible. As there is growing evidence in the literature that DMSO can affect cellular pathways leading to numerous changes, it is important to expand our knowledge concerning this issue.

Indexed as

Cell LineCell ProliferationDimethyl SulfoxideFibroblastsGene Expression RegulationGenisteinGlycosaminoglycansHumansIsoflavonesLysosomal Storage DiseasesLysosomesMucopolysaccharidosesDimethyl SulfoxideGenisteinGlycosaminoglycansIsoflavonesdimethyl sulfoxide (DMSO)glycosamoninoglycans (GAGs) therapylysosomal storage diseasesmucopolysaccharidosis type III (MPS IIISanfilippo syndrome)

Identifiers

PMID30646511
PMCPMC6359599
OpenAlexW2909947694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.